Low incidence of COVID-19 in hidradenitis suppurativa: How to interpret it?

Dewigne, Mathilde; Orte Cano, Carmen; Daoud, Mathieu; Del Marmol, Véronique; Benhadou, Farida

Dewigne, Mathilde; Orte Cano, Carmen; Daoud, Mathieu; Del Marmol, Véronique; Benhadou, Farida.

Dewigne M; Dermatology Department, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Orte Cano C; Dermatology Department, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Daoud M; Dermatology Department, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.
Del Marmol V; European Hidradenitis Suppurativa Foundation e.V, Dessau, Germany.
Benhadou F; Dermatology Department, Hôpital Universitaire Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Exp Dermatol ; 31(3): 435-436, 2022 03.

Article in English | MEDLINE | ID: covidwho-1480117

Subject(s)

COVID-19; Hidradenitis Suppurativa; Hidradenitis Suppurativa/epidemiology; Hidradenitis Suppurativa/etiology; Humans; Incidence; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hidradenitis Suppurativa / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Exp Dermatol Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Exd.14475

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google